Document:

Exhibit 10.1

      

       

      

      AMENDED AND RESTATED ROYALTY AGREEMENT

      AND DISTRIBUTION AGREEMENT

       

      This Amended and Restated Royalty Agreement and Distribution Agreement (this “Agreement”) is entered into as of March 22, 2021 by and between Brooklyn
        Immunotherapeutics, LLC, a Delaware limited liability company with offices located at Brooklyn Army Terminal, 140 58th Street, Bldg. A, Suite 2100, Brooklyn, NY 11220 (the “Company”), Brooklyn
        Immunotherapeutics Investors GP LLC, a Delaware limited liability company (“Investors GP”), Brooklyn Immunotherapeutics Investors LP, a Delaware limited partnership (“Investors

          LP”), and the beneficiary parties listed on Schedule A (“the “Holders”).  Each of the Company, Investors GP, Investors LP and the Holders are jointly referred to herein as the “Parties” and each, individually, as a “Party.”

       

      WHEREAS, Company is a party to a royalty agreement dated November 6, 2018, by and between Investors LP and Investors GP (the “2018 Royalty Agreement”);

       

      WHEREAS, the Company has entered into a reverse merger transaction which will result in dissolving Investors LP and Investors GP (the “Transaction”);

       

      WHEREAS, prior to the Transaction, the Company desires to amend and restate the 2018 Royalty Agreement to modify the terms of the royalty arrangement such that the royalties would be paid directly
        to the beneficial holders of units in the Company.  Company has previously granted to Investors LP and Investors GP royalties from the sale of certain products, and which pursuant to this Agreement, Investors LP and Investors GP are distributing
        such royalty payments to Holders and Holders have agreed to accept, the royalty payments described below on the terms and conditions set forth herein. This Agreement shall amend and restate the 2018 Royalty Agreement;

       

      NOW THEREFORE, in consideration of these premises and the covenants herein contained, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged,
        the Parties mutually agree as follows:

       

      1.            Recitals. The foregoing recitals are hereby incorporated into this Agreement.

       

      2.            Distribution. Investors GP and Investors LP hereby distributes all of their rights, title and interest in and to the Royalty (defined below)
        to the Holders. Company shall cause the distribution to be reflected on the books of the Company.

       

      3.            Royalty.

       

      (a)          Royalty Payments. In consideration of the provision of the financing for the Transactions by the Holders, Company agrees pay to the Holders during the Royalty Term compensatory
        royalties in an amount equal to four percent (4%) of the Net Revenues received by Company during the applicable year, of which 75% shall be paid to the holders listed as the LP Holders and 25% shall be paid to GP Holders (the “Royalty”). For the avoidance of any doubt, the LP Holders shall receive 3% of the Net Revenues and the GP Holders shall receive 1% of the Net Revenues. Company shall pay the Royalty within thirty (30) days after
        the end of each calendar year of the Royalty Term. “Net Revenues” shall mean all revenues received by Company from the sale or license of its IRX-2 products, minus discounts, and sales returns and allowance.

       

      
        1

        
          

      

      (b)          Royalty Term. The term of the Royalty shall commence on the date hereof and will continue in perpetuity (the “Royalty Term”).

       

      (c)         Royalty Reports; Records. Company shall report to the Holders the Net Revenues on which Holders are entitled to Royalties hereunder on an annual basis during the Term; provided
        however, upon the commencement of royalty payments, the Company shall provide the report on a quarterly basis during the term (each, a “Royalty Report”).

       

      (d)          Form of Payment. All Royalty payments shall be made in U.S. dollars. Any monies payable to the Holders shall be paid by Company via check or wire transfer to an account
        designated in writing by each Investor to Company. In the event Company is unable to pay the full amount of a quarterly Royalty payment when due, Company shall use good faith efforts to pay such amount promptly (as soon as Company has available
        funds) and such unpaid amount shall accrue interest at the rate of twelve percent (12%) per year from the date such amount of Royalties were due until paid in full.

       

      (e)         Taxes. All payments under this Agreement are exclusive of all federal, state, local and foreign taxes, levies and assessments. Each Investor agrees to bear and be responsible
        for the payment of all such taxes, levies and assessments imposed upon such Investor arising out of its receipt of payments from Company under this Agreement. If Company reasonably determines in its sole discretion that it is or could be obligated
        to withhold any tax in connection with the Royalty, Company may, in its reasonable discretion, withhold the appropriate amount of tax in cash from the Royalty, provided that Company gives the applicable Investor notice of such determination and an
        opportunity to comment on or object to such determination. If Company does not withhold an amount sufficient to satisfy the withholding obligation of Company, the applicable Investor will, on demand, reimburse Company in cash for the amount which
        should have been withheld.

       

      4.            Confidential Information.

       

      (a)        Protection and Use of Confidential Information. No Party shall disclose or use the Confidential Information of the other Party, except as expressly authorized pursuant to this
        Agreement. The receiving Party shall limit disclosure of the disclosing Party’s Confidential Information to the receiving Party’s employees or agents who have a need to know such Confidential Information for purposes of this Agreement.
        Notwithstanding the foregoing, Confidential Information may be disclosed if required by law, provided, however, that the receiving Party shall notify the disclosing Party of such requirement immediately in writing and shall reasonably cooperate
        with the disclosing Party in obtaining a protective or similar order.

       

      (b)          Exceptions. Confidential Information will not include information that: (i) is in or enters the public domain through no act or fault of the receiving Party; (ii) is known to
        and has been reduced to tangible form by the receiving Party at the time of disclosure; (iii) is independently developed by the receiving Party without use of or reference to the disclosing Party’s Confidential Information; or (iv) is disclosed to
        the receiving Party by a third party, at any time, whether prior to or after the time of its disclosure under this Agreement, on a non-confidential basis, provided that such third party is not, to the receiving Party’s knowledge, bound by any
        obligation of confidentiality to the disclosing Party with respect to such Confidential Information.

       

      
        2

        
          

      

      (c)          Return of Confidential Information. Upon the disclosing Party’s written request, the receiving Party shall return or destroy all copies of the disclosing Party’s Confidential
        Information and certify promptly in writing that it has done so.

       

      (d)         Definition. As used herein, “Confidential Information” shall mean a Party’s non-public technical or business information, including
        without limitation, the Royalty Report, trade secrets, know-how, inventions, technical data or specifications, testing methods, business or financial information, research and development activities, product and marketing plans, and customer and
        supplier information. Furthermore, the terms and conditions of this Agreement shall be considered the Confidential Information of all Parties.

       

      5.            Miscellaneous.

       

      (a)        Headings, Integration, Revisions. All headings are for reference purposes only and will not affect the meaning or interpretation of this Agreement. This Agreement of even date
        herewith merges all prior representations and collateral understandings, memorandums and agreements in connection with its subject matter, and constitutes the entire understanding between the Holders and Company concerning the subject matter of
        this Agreement. No Party shall be bound by any revision of this Agreement unless in writing and signed by an authorized officer of said Party.

       

      (b)         Applicable Law and Interpretation. All questions concerning the validity, operation, interpretation, and construction of the Agreement will be governed by and determined in
        accordance with the substantive laws of the State of New York without regard to its conflicts of law provisions. Any action brought pursuant to or in connection with this Agreement shall be brought only in the state or federal courts within New
        York County, New York. In any such action, all Parties consent to the exercise of personal jurisdiction of such courts and waive any objections to venue in any such forum. THE PARTIES HERETO EXPRESSLY WAIVE ANY RIGHT THEY MAY HAVE TO A TRIAL BY
        JURY.

       

      (c)          Assignment. No Party may assign this Agreement without the prior written consent of the other Parties.

       

      (d)          Notices. Notices pertaining to this Agreement shall be in writing and shall be deemed received by the addressee when delivered, if delivered in person or by receipted courier,
        five (5) business days after being deposited in the United States mail, postage prepaid, certified or registered mail or when delivered via electronic mail, provided that a copy is sent via United State mail or express mail. Notices shall be
        addressed to the other Party at its respective address set forth in the preamble hereof or to such address as is communicated to each Party in writing.

       

      (e)          Severability. If any provision of this Agreement is unenforceable, such provision will be changed and interpreted to accomplish the objectives of such provision to the greatest
        extent possible under applicable law and the remaining provisions will continue in full force and effect.

       

      
        3

        
          

      

      (f)          Independent Contractors, No Joint Venture. The Holders and Company acknowledge and agree that each is an independent contractor and neither shall be considered an employee,
        agent, partner or co-venturer of the other. It is understood that neither the Holders nor Company shall have the right or authority to make any commitments or incur any costs on behalf of the other. This Agreement does not constitute, and shall not
        be construed as constituting, a partnership or joint venture between Company and the Holders. Nothing herein contained shall give or is intended to give any rights of any kind to any third party.

       

      (g)          Waiver. No delay on the part of a Party in exercising any of its rights, remedies, powers and privileges hereunder or partial or single exercise thereof, shall constitute a
        waiver thereof. The waiver by any Party of any default or breach, or of any claimed default or claimed breach, of this Agreement shall not constitute a waiver of any other or subsequent default or breach. No notice to or demand on any Party hereto
        in any case shall entitle such Party to any other or further notice or demand in similar or other circumstances or constitute a waiver of any of the rights of the other Party hereto to any other or further action in any circumstances without notice
        or demand.

       

      (h)        Counterparts. This Agreement may be executed in multiple counterparts, each of which shall be deemed an original and all of which taken together shall constitute one and the same
        instrument. The delivery of signed counterparts by facsimile or e-mail transmission that includes a copy of the sending Party’s signature is as effective as signing and delivering the counterpart in person.

       

      [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

       

      
        4

        
          

      

      IN WITNESS WHEREOF the Parties hereto have executed this Agreement as of the Effective Date.

       

      	 	
              Brooklyn Immunotherapeutics, LLC

            
	 	 	 
	 	By:	
              /s/Charles R. Cherington

            
	 	 	
              Name: Charles R. Cherington

            
	 	 	
              Title: Manager

            
	 	 	 
	 	
              Brooklyn Immunotherapeutics Investors LP

            
	 	By:	
              Brooklyn Immunotherapeutics Investors GP LLC, its General Partner

            
	 	 	 
	 	By:	
              /s/Charles R. Cherington

            
	 	 	
              Name: Charles R. Cherington

            
	 	 	
              Title: Manager

            
	 	 	 
	 	
              Brooklyn Immunotherapeutics Investors GP LLC

            
	 	 	 
	 	By:	
              /s/Charles R. Cherington

            
	 	 	
              Name: Charles R. Cherington

            
	 	 	
              Title: Manager

            

       

      

      
        [Signature page to Royalty Agreement]

         

        

      

      
        5

        
          

      

      Schedule A

       

      Beneficial Holders

       

      GP Holders

       

      	
              Name

            	
              Percent of Total

            
	 	 
	
              [***]

            	
              [***]

            
	 	 
	
              Charles Cherington

            	
              16.81%

            
	 	 
	
              Denny Family Partners II, LLC

            	
              16.81%

            
	 	 
	
              George P. Denny Trust

            	
              0.12%

            
	 	 
	
              John D. Halpern Revocable Trust

            	
              14.01%

            
	 	 
	PCI BI LLC

            	 8.40%
	 	 
	
              The Yiannis Monovoukass Family 2013 Revocable Trust FBO Alexi Monovoukas

            	
              1.87%

            
	 	 
	
              The Yiannis Monovoukass Family 2013 Revocable Trust FBO Aresti Monovoukas-

            	
              1.87%

            
	 	 
	
              The Yiannis Monovoukass Family 2013 Revocable Trust FBO Christian Monovoukas

            	
              1.87%

            
	 	 
	 	
              100.00%

            

      

      

      LP Holders

       

      	
              Name

            	
              Percent of Total

            
	 	 
	
              [***]

            	
              [***]

            
	 	 
	
              R. Breck Denny Trust

            	
              0.22%

            
	 	 
	 	
              100.00%

            

      

      

      
        [Schedule A to Amended and Restated Royalty Agreement

        and Distribution Agreement]

        

        

      

       

         6Exhibit 10.2

       

     

       

    
      BROOKLYN IMMUNOTHERAPEUTICS, INC.

      2020 STOCK INCENTIVE PLAN

       

      	1.	
              ESTABLISHMENT, EFFECTIVE DATE AND TERM

            

       

      Brooklyn Immunotherapeutics, Inc. (f/k/a NTN Buzztime, Inc.), a Delaware corporation (the "Company"), hereby establishes the Brooklyn Immunotherapeutics, Inc. 2020 Stock
        Incentive Plan (the "Plan"). The "Effective Date" of the Plan shall be the later of: (i) the date the Plan was approved by the Board, and (ii) the date the Plan was approved by the stockholders of the Company in accordance with the laws of
        the State of Delaware, or such later date as provided in the resolutions adopting the Plan; provided, however, that no Award may be granted unless and until the Plan has been approved by the stockholders
        of the Company. Unless earlier terminated pursuant to Section 15(k) hereof, the Plan shall terminate on the tenth anniversary of the Effective Date. Capitalized terms used herein are defined in Appendix A attached hereto.

       

      	2.	
              PURPOSE

            

       

      The purpose of the Plan is to enable the Company to attract, retain, reward and motivate Eligible Individuals by providing them with an opportunity to acquire or increase a
        proprietary interest in the Company and to incentivize them to expend maximum effort for the growth and success of the Company, so as to strengthen the mutuality of the interests between the Eligible Individuals and the stockholders of the Company.

       

      	3.	
              ELIGIBILITY

            

       

      Awards may be granted under the Plan to any Eligible Individual, as determined by the Committee from time to time, based on their importance to the business of the Company,
        pursuant to the terms of the Plan.

       

      	4.	
              ADMINISTRATION

            

       

      	

               	a.	
              Committee. The Plan shall be administered by the Committee, which shall have the full power and authority to take all actions, and to
                  make all determinations not inconsistent with the specific terms and provisions of the Plan and deemed by the Committee to be necessary or appropriate to the administration of the Plan, any Award granted or any Award Agreement entered
                  into hereunder. The Committee may correct any defect or supply any omission or reconcile any inconsistency in the Plan or in any Award Agreement in the manner and to the extent it shall deem expedient to carry the Plan into effect as it
                  may determine in its sole discretion. The decisions by the Committee shall be final, conclusive and binding with respect to the interpretation and administration of the Plan, any Award or any Award Agreement entered into under the Plan.
                  The Committee may, in its sole discretion, accelerate the vesting, exercisability or lapse of restrictions with respect to any Award, provided that the exercise of such discretion is not otherwise prohibited by the Plan or violates the
                  requirements of the Code.

            

       

      	

               	b.	
              Delegation to Officers or Employees. The Committee may designate officers or employees of the Company to assist the Committee in the
                  administration of the Plan. The Committee may delegate authority to officers or employees of the Company to grant Awards and execute Award Agreements or other documents on behalf of the Committee in connection with the administration of
                  the Plan, subject to whatever limitations or restrictions the Committee may impose in accordance with applicable law and to the extent that such delegation will not result in the loss of an exemption under Rule 16b-3(d)(1) for Awards
                  granted to Participants subject to Section 16 of the Exchange Act in respect of the Company and will not result in a related-person transaction with an executive officer required to be disclosed under Item 404(a) of Regulation S-K (in
                  accordance with Instruction 5.a.ii thereunder) under the Exchange Act.

            

       

      
        
          

      

      
      	

               	c.	
              Designation of Advisors. The Committee may designate professional advisors to assist the Committee in the administration of the Plan.
                  The Committee may employ such legal counsel, consultants, and agents as it may deem desirable for the administration of the Plan and may rely upon any advice and any computation received from any such counsel, consultant, or agent. The
                  Company shall pay all expenses and costs incurred by the Committee for the engagement of any such counsel, consultant, or agent.

            

       

      	

               	d.	
              Participants Outside the U.S. In order to conform with the provisions of local laws and regulations of foreign countries which may
                  affect the Awards or the Participants, the Committee shall have the sole discretion to (i) modify the terms and conditions of the Awards granted under the Plan to Eligible Individuals located outside the United States; (ii) establish
                  subplans with such modifications as may be necessary or advisable under the circumstances present by local laws and regulations; and (iii) take any action which it deems advisable to comply with or otherwise reflect any necessary
                  governmental regulatory procedures, or to obtain any exemptions or approvals necessary with respect to the Plan or any subplan established hereunder.

            

       

      	

               	e.	
              Liability and Indemnification. No Covered Individual shall be liable for any action or determination made in good faith with respect to
                  the Plan, any Award granted hereunder or any Award Agreement entered into hereunder. The Company shall, to the maximum extent permitted by applicable law and its Certificate of Incorporation and Bylaws, indemnify and hold harmless each
                  Covered Individual against any cost or expense (including reasonable attorney fees reasonably acceptable to the Company) or liability (including any amount paid in settlement of a claim with the approval of the Company), and amounts
                  advanced to such Covered Individual necessary to pay the foregoing at the earliest time and to the fullest extent permitted, arising out of any act or omission to act in connection with the Plan, any Award granted hereunder or any Award
                  Agreement entered into hereunder. Such indemnification shall be in addition to any rights of indemnification such individuals may have under other agreements, applicable law or under the Certificate of Incorporation or Bylaws of the
                  Company. Notwithstanding anything else herein, this indemnification will not apply to the actions or determinations made by a Covered Individual with regard to Awards granted to such Covered Individual under the Plan or arising out of
                  such Covered Individual's own fraud or bad faith.

            

       

      	5.	
              SHARES OF COMMON STOCK SUBJECT TO THE PLAN

            

       

      	

               	a.	
              Shares Available for Awards. The Common Stock that may be issued pursuant to Awards granted under the Plan shall be treasury shares or
                  authorized but unissued shares of the Common Stock. The total number of shares of Common Stock that may be issued pursuant to Awards granted under the Plan shall be 3,368,804 shares.

            

       

      	

               	b.	
              Certain Limitations on Specific Types of Awards. The granting of Awards under this Plan shall be subject to the following limitations:

            

       

      	

               	i.	
              With respect to the shares of Common Stock reserved pursuant to this Section, a maximum of 3,368,804 shares may be subject to grants of Incentive Stock Options.

            

       

      	

               	ii.	
              With respect to the shares of Common Stock reserved pursuant to this Section, a maximum of 3,368,804 of such shares may be issued in connection with Awards, other than Options and Stock Appreciation Rights, that
                are settled in Common Stock.

            

       

      	

               	c.	
              Reduction of Shares Available for Awards. Upon the granting of an Award, the number of shares of Common Stock available for issuance
                  under this Section for the granting of further Awards shall be reduced as follows:

            

       

      
        2

        
          

      

      	

               	i.	
              In connection with the granting of an Option or Stock Appreciation Right, the number of shares of Common Stock shall be reduced by the number of shares of Common Stock subject to the Option or Stock Appreciation
                Right;

            

       

      	

               	ii.	
              In connection with the granting of an Award that is settled in Common Stock, other than the granting of an Option or Stock Appreciation Right, the number of shares of Common Stock shall be reduced by the number
                of shares of Common Stock subject to the Award; and

            

       

      	

               	iii.	
              Awards settled in cash or property other than Common Stock shall not count against the total number of shares of Common Stock available to be granted pursuant to the Plan.

            

       

      	

               	d.	
              Cancelled, Forfeited or Surrendered Awards. Notwithstanding anything to the contrary in this Plan, if any Award is cancelled, forfeited
                  or terminated for any reason prior to exercise, delivery or becoming vested in full, the shares of Common Stock that were subject to such Award shall, to the extent cancelled, forfeited or terminated, immediately become available for
                  future Awards granted under this Plan, as if said Awards had never been granted; provided, however, that any shares of Common Stock subject to an Award which is cancelled, forfeited or terminated in order to pay the exercise price of a
                  stock option, purchase price or any taxes or tax withholdings on an Award shall not be available for future Awards granted under this Plan.

            

       

      	

               	e.	
              Recapitalization. If the outstanding shares of Common Stock are increased or decreased or changed into or exchanged for a different
                  number or kind of shares or other securities by reason of any recapitalization, reclassification, reorganization, stock split, reverse split, combination of shares, exchange of shares, stock dividend or other distribution payable in
                  capital stock of the Company or other increase or decrease in such shares effected without receipt of consideration by the Company occurring after the Effective Date, an appropriate and proportionate adjustment shall be made by the
                  Committee including to: (i) the limits with respect to number and kind of shares (including, but not limited to, the limits of the number of shares of Common Stock described in Section 5(a)), (ii) the calculation of the reduction of
                  shares of Common Stock available under the Plan, (iii) the number and kind of shares of Common Stock issuable pursuant to outstanding Awards granted under the Plan and/or (iv) the Exercise Price of outstanding Options or Stock
                  Appreciation Rights granted under the Plan. No fractional shares of Common Stock or units of other securities shall be issued pursuant to any such adjustment under this Section 5(e), and any fractions resulting from any such adjustment
                  shall be eliminated in each case by rounding downward to the nearest whole share or unit. Any adjustments made under this Section 5(e) with respect to any Incentive Stock Options must be made in accordance with Code Section 424.

            

       

      	6.	
              OPTIONS

            

       

      	

               	a.	
              Grant of Options. Subject to the terms and conditions of the Plan, the Committee may grant to such Eligible Individuals as the Committee
                  may determine, Options to purchase such number of shares of Common Stock and on such terms and conditions as the Committee shall determine in its sole and absolute discretion. Each grant of an Option shall satisfy the requirements set
                  forth in this Section.

            

       

      	

               	b.	
              Type of Options. Each Option granted under the Plan may be designated by the Committee, in its sole discretion, as either (i) an
                  Incentive Stock Option, or (ii) a Non-Qualified Stock Option. Options designated as Incentive Stock Options that fail to continue to meet the requirements of Code Section 422 shall be re-designated as Non-Qualified Stock Options
                  automatically on the date of such failure to continue to meet such requirements without further action by the Committee. In the absence of any designation, Options granted under the Plan will be deemed to be Non-Qualified Stock Options.

            

       

      
        3

        
          

      

      	

               	c.	
              Exercise Price. Subject to the limitations set forth in the Plan relating to Incentive Stock Options, the Exercise Price of an Option
                  shall be fixed by the Committee and stated in the respective Award Agreement, provided that the Exercise Price of the shares of Common Stock subject to such Option may not be less than Fair Market Value of such Common Stock on the Grant
                  Date, or if greater, the par value of the Common Stock.

            

       

      	

               	d.	
              Limitation on Option Period. Subject to the limitations set forth in the Plan relating to Incentive Stock Options, Options granted under
                  the Plan and all rights to purchase Common Stock thereunder shall terminate no later than the tenth anniversary of the Grant Date of such Options, or on such earlier date as may be stated in the Award Agreement relating to such Option. In
                  the case of Options expiring prior to the tenth anniversary of the Grant Date, the Committee may in its discretion, at any time prior to the expiration or termination of said Options, extend the term of any such Options for such
                  additional period as it may determine, but in no event beyond the tenth anniversary of the Grant Date thereof.

            

       

      	

               	e.	
              Limitations on Incentive Stock Options. Notwithstanding any other provisions of the Plan, the following provisions shall apply with
                  respect to Incentive Stock Options granted pursuant to the Plan.

            

       

      	

               	i.	
              A maximum of 3,368,804 shares may be subject to grants of Incentive Stock Options.

            

       

      	

               	ii.	
              Limitation on Grants. Incentive Stock Options may only be granted to Section 424 Employees. The aggregate Fair Market
                  Value (determined at the time such Incentive Stock Option is granted) of the shares of Common Stock for which any individual may have Incentive Stock Options which first become vested and exercisable in any calendar year (under all
                  incentive stock option plans of the Company) shall not exceed $100,000. Options granted to such individual in excess of the $100,000 limitation, and any Options issued subsequently which first become vested and exercisable in the same
                  calendar year, shall automatically be treated as Non-Qualified Stock Options.

            

       

      	

               	iii.	
              Minimum Exercise Price. In no event may the Exercise Price of a share of Common Stock subject an Incentive Stock Option be
                  less than 100% of the Fair Market Value of such share of Common Stock on the Grant Date.

            

       

      	

               	iv.	
              Ten Percent Stockholder. Notwithstanding any other provision of the Plan to the contrary, in the case of Incentive Stock
                  Options granted to a Section 424 Employee who, at the time the Option is granted, owns (after application of the rules set forth in Code Section 424(d)) stock possessing more than ten percent of the total combined voting power of all
                  classes of stock of the Company, such Incentive Stock Options (i) must have an Exercise Price per share of Common Stock that is at least 110% of the Fair Market Value as of the Grant Date of a share of Common Stock, and (ii) must not be
                  exercisable after the fifth anniversary of the Grant Date.

            

       

      	

               	f.	
              Vesting Schedule and Conditions. No Options may be exercised prior to the satisfaction of the conditions and vesting schedule provided
                  for in the Plan and in the Award Agreement relating thereto. Except as otherwise provided by the Committee, Options covered by any Award under this Plan that are subject solely to a future service requirement shall vest, subject to
                  Sections 10, 12 and 13 of the Plan, as follows: (i) 20% of the Options subject to an Award shall vest immediately upon the Grant Date; and (ii) the remaining 80% of the Options subject to an Award shall vest over the four-year period
                  immediately following the Grant Date in equal annual increments of 20%, with one increment vesting on each anniversary date of the Grant Date.

            

       

      
        4

        
          

      

      	

               	g.	
              Exercise. When the conditions to the exercise of an Option have been satisfied, the Participant may exercise the Option only in
                  accordance with the following provisions. The Participant shall deliver to the Company a written notice stating that the Participant is exercising the Option and specifying the number of shares of Common Stock which are to be purchased
                  pursuant to the Option, and such notice shall be accompanied by payment in full of the Exercise Price of the shares for which the Option is being exercised, by one or more of the methods provided for in the Plan. Said notice must be
                  delivered to the Company at its principal office and addressed to the attention of the Chief Financial Officer. An attempt to exercise any Option granted hereunder other than as set forth in the Plan shall be invalid and of no force and
                  effect.

            

       

      	

               	h.	
              Payment. Payment of the Exercise Price for the shares of Common Stock purchased pursuant to the exercise of an Option shall be made by
                  one of the following methods:

            

       

      	

               	i.	
              by cash, certified or cashier's check, bank draft or money order;

            

       

      	

               	ii.	
              through the delivery to the Company of shares of Common Stock which have been previously owned by the Participant for the requisite period necessary to avoid a charge to the Company's earnings for financial
                reporting purposes; such shares shall be valued, for purposes of determining the extent to which the Exercise Price has been paid thereby, at their Fair Market Value on the date of exercise; without limiting the foregoing, the Committee may
                require the Participant to furnish an opinion of counsel acceptable to the Committee to the effect that such delivery would not result in the Company incurring any liability under Section 16(b) of the Exchange Act; or

            

       

      	

               	iii.	
              by any other method which the Committee, in its sole and absolute discretion and to the extent permitted by applicable law, may permit, including, but not limited to through a "cashless exercise sale and
                remittance procedure" pursuant to which the Participant shall concurrently provide irrevocable instructions (1) to a brokerage firm approved by the Committee to effect the immediate sale of the purchased shares and remit to the Company, out
                of the sale proceeds available on the settlement date, sufficient funds to cover the aggregate Exercise Price payable for the purchased shares plus all applicable federal, state and local income, employment, excise, foreign and other taxes
                required to be withheld by the Company by reason of such exercise and (2) to the Company to deliver the certificates for the purchased shares directly to such brokerage firm in order to complete the sale.

            

       

      	

               	i.	
              Termination of Employment. Unless otherwise provided in an Award Agreement, upon the termination of the employment and other service of
                  a Participant with the Company Group for any reason, all of the Participant's outstanding Options (whether vested or unvested) shall be subject to the rules of this paragraph. Upon such termination, the Participant's unvested Options
                  shall expire. Notwithstanding anything in this Plan to the contrary, the Committee may provide, in its sole and absolute discretion, that following the termination of employment and other service of a Participant with the Company Group
                  for any reason (i) any unvested Options held by the Participant that vest solely upon a future service requirement shall vest in whole or in part, at any time subsequent to such termination of employment and other service, and/or (ii) a
                  Participant or the Participant's estate, devisee or heir at law (whichever is applicable), may exercise an Option, in whole or in part, at any time subsequent to such termination of employment and other service and prior to the
                  termination of the Option pursuant to its terms that are unrelated to termination of service. Unless otherwise determined by the Committee, temporary absence from employment and other service because of illness, vacation, approved leaves
                  of absence or military service shall not constitute a termination of employment or other service.

            

       

      
        5

        
          

      

      	

               	i.	
              Termination for Reason other than Cause, Disability or Death. If a Participant's termination of employment and other
                  service is for any reason other than death, Disability, Cause and other service by the Company for Cause, any Option held by such Participant may be exercised, to the extent exercisable at termination, by the Participant at any time
                  within a period not to exceed ninety (90) days from the date of such termination, but in no event after the termination of the Option pursuant to its terms that are unrelated to termination of service.

            

       

      	

               	ii.	
              Disability. If a Participant's termination of employment and other service with the Company is by reason of a Disability
                  of such Participant, any Option held by such Participant may be exercised, to the extent exercisable at termination, by the Participant at any time within a period not to exceed one (1) year after such termination, but in no event after
                  the termination of the Option pursuant to its terms that are unrelated to termination of service; provided, however, that if the Participant dies within such period, any vested Option held by such Participant upon death shall be
                  exercisable by the Participant's estate, devisee or heir at law (whichever is applicable) for a period not to exceed one (1) year after the Participant's death, but in no event after the termination of the Option pursuant to its terms
                  that are unrelated to termination of service.

            

       

      	

               	iii.	
              Death. If a Participant dies while in the employment or other service of the Company, any Option held by such Participant
                  may be exercised, to the extent exercisable at termination, by the Participant's estate or the devisee named in the Participant's valid last will and testament or the Participant's heir at law who inherits the Option, at any time within a
                  period not to exceed one (1) year after the date of such Participant's death, but in no event after the termination of the Option pursuant to its terms that are unrelated to termination of service.

            

       

      	

               	iv.	
              Termination for Cause. In the event the termination is for Cause, any Option held by the Participant at the time of such
                  termination shall be deemed to have terminated and expired upon the date of such termination.

            

       

      	7.	
              STOCK APPRECIATION RIGHTS

            

       

      	

               	a.	
              Grant of Stock Appreciation Rights. Subject to the terms and conditions of the Plan, the Committee may grant to such Eligible
                  Individuals as the Committee may determine, Stock Appreciation Rights, in such amounts and on such terms and conditions, as the Committee shall determine in its sole and absolute discretion. Each grant of a Stock Appreciation Right shall
                  satisfy the requirements as set forth in this Section.

            

       

      	

               	b.	
              Terms and Conditions of Stock Appreciation Rights. Unless otherwise provided in an Award Agreement, the terms and conditions (including,
                  without limitation, the limitations on the Exercise Price, exercise period, repricing and termination) of the Stock Appreciation Right shall be substantially identical (to the extent possible taking into account the differences related to
                  the character of the Stock Appreciation Right) to the terms and conditions that would have been applicable under Section 6 above were the grant of the Stock Appreciation Rights a grant of an Option.

            

       

      	

               	c.	
              Exercise of Stock Appreciation Rights. Stock Appreciation Rights shall be exercised by a Participant only by written notice delivered to
                  the Chief Financial Officer of the Company, specifying the number of shares of Common Stock with respect to which the Stock Appreciation Right is being exercised.

            

       

      
        6

        
          

      

      	

               	d.	
              Payment of Stock Appreciation Right. Unless otherwise provided in an Award Agreement, upon exercise of a Stock Appreciation Right, the
                  Participant or Participant's estate, devisee or heir at law (whichever is applicable) shall be entitled to receive payment, in cash, in shares of Common Stock, or in a combination thereof, as determined by the Committee in its sole and
                  absolute discretion. The amount of such payment shall be determined by multiplying the excess, if any, of the Fair Market Value of a share of Common Stock on the date of exercise over the Fair Market Value of a share of Common Stock on
                  the Grant Date, by the number of shares of Common Stock with respect to which the Stock Appreciation Rights are then being exercised. Notwithstanding the foregoing, the Committee may limit in any manner the amount payable with respect to
                  a Stock Appreciation Right by including such limitation in the Award Agreement.

            

       

      	8.	
              RESTRICTED STOCK

            

       

      	

               	a.	
              Grant of Restricted Stock. Subject to the terms and conditions of the Plan, the Committee may grant to such Eligible Individuals as the
                  Committee may determine, Restricted Stock, in such amounts and on such terms and conditions as the Committee shall determine in its sole and absolute discretion. Each grant of Restricted Stock shall satisfy the requirements as set forth
                  in this Section.

            

       

      	

               	b.	
              Restrictions. The Committee shall impose such restrictions on any Restricted Stock granted pursuant to the Plan as it may deem advisable
                  including, without limitation, time-based vesting restrictions or the attainment of Performance Goals. Except as otherwise provided by the Committee in its sole and absolute discretion and subject to Sections 10, 12 and 13 of the Plan,
                  Restricted Stock covered by any Award under this Plan that are subject solely to a future service requirement shall vest over the four-year period immediately following the Grant Date in equal annual increments of 25%, with one increment
                  vesting on each anniversary date of the Grant Date.

            

       

      	

               	c.	
              Certificates and Certificate Legend. With respect to a grant of Restricted Stock, the Company may issue a certificate evidencing such
                  Restricted Stock to the Participant or issue and hold such shares of Restricted Stock for the benefit of the Participant until the applicable restrictions expire. The Company may legend the certificate representing Restricted Stock to
                  give appropriate notice of such restrictions. In addition to any such legends, each certificate representing shares of Restricted Stock granted pursuant to the Plan shall bear the following legend:

            

       

      "Shares of stock represented by this certificate are subject to certain terms, conditions, and restrictions on transfer as set forth in the Brooklyn Immunotherapeutics, Inc. 2020
        Stock Incentive Plan (the "Plan"), and in an agreement entered into by and between the registered owner of such shares and Brooklyn Immunotherapeutics, Inc. (the "Company"), dated , 202_ (the "Award Agreement"). A copy of the Plan and the Award
        Agreement may be obtained from the Secretary of the Company."

       

      	

               	d.	
              Removal of Restrictions. Except as otherwise provided in the Plan or the Award Agreement, shares of Restricted Stock shall become freely
                  transferable by the Participant upon the lapse of the applicable restrictions. Once the shares of Restricted Stock are released from the restrictions, the Participant shall be entitled to have the legend required by paragraph (c) above
                  removed from the share certificate evidencing such Restricted Stock and the Company shall pay or distribute to the Participant all dividends and distributions held in escrow by the Company with respect to such Restricted Stock, if any.

            

       

      
        7

        
          

      

      	

               	e.	
              Stockholder Rights. Unless otherwise provided in an Award Agreement, until the expiration of all applicable restrictions, (i) the
                  Restricted Stock shall be treated as outstanding, (ii) the Participant holding shares of Restricted Stock may exercise full voting rights with respect to such shares, and (iii) the Participant holding shares of Restricted Stock shall be
                  entitled to receive all dividends and other distributions paid with respect to such shares while they are so held. All dividends and distributions shall be held in escrow by the Company (subject to the same restrictions on forfeitability)
                  until all restrictions on the respective Restricted Stock have lapsed. If any such dividends or distributions are paid in shares of Common Stock, such shares shall be subject to the same restrictions on transferability and forfeitability
                  as the shares of Restricted Stock with respect to which they were paid.

            

       

      	

               	f.	
              Termination of Service. Unless otherwise provided in an Award Agreement, if a Participant's employment and other service with the
                  Company terminates for any reason, all unvested shares of Restricted Stock held by the Participant and any dividends or distributions held in escrow by the Company with respect to such Restricted Stock shall be forfeited immediately and
                  returned to the Company. Notwithstanding this paragraph, all grants of Restricted Stock that vest solely upon the attainment of Performance Goals shall be treated pursuant to the terms and conditions that would have been applicable under
                  Section 9 as if such grants of Restricted Stock were Awards of Performance Shares, to the extent such terms and conditions are applicable to shares of Restricted Stock. Notwithstanding anything in this Plan to the contrary, the Committee
                  may provide, in its sole and absolute discretion, that following the termination of employment and other service of a Participant with the Company for any reason, any unvested shares of Restricted Stock held by the Participant that vest
                  solely upon a future service requirement shall vest in whole or in part, at any time subsequent to such termination of employment and other service.

            

       

      	9.	
              PERFORMANCE SHARES, PERFORMANCE UNITS AND RSUs

            

       

      	

               	a.	
              Grant of Performance Shares, Performance Units and RSUs. Subject to the terms and conditions of the Plan, the Committee may grant to
                  such Eligible Individuals as the Committee may determine, Performance Shares, Performance Units and RSUs, in such amounts and on such terms and conditions as the Committee shall determine in its sole and absolute discretion. Each grant of
                  a Performance Share, a Performance Unit or an RSU shall satisfy the requirements as set forth in this Section.

            

       

      	

               	b.	
              Performance Goals. Performance Goals will be based on one or more of the following criteria, as determined by the Committee in its
                  absolute and sole discretion: (i) the attainment of certain target levels of, or a specified increase in, the Company's enterprise value or value creation targets; (ii) the attainment of certain target levels of, or a percentage increase
                  in, the Company's after-tax or pre-tax profits including, without limitation, that attributable to the Company's continuing and/or other operations; (iii) the attainment of certain target levels of, or a specified increase relating to,
                  the Company's operational cash flow or working capital, or a component thereof; (iv) the attainment of certain target levels of, or a specified decrease relating to, the Company's operational costs, or a component thereof; (v) the
                  attainment of a certain level of reduction of, or other specified objectives with regard to limiting the level of increase in all or a portion of bank debt or other of the Company's long-term or short-term public or private debt or other
                  similar financial obligations of the Company, which may be calculated net of cash balances and/or other offsets and adjustments as may be established by the Committee; (vi) the attainment of a specified percentage increase in earnings per
                  share or earnings per share from the Company's continuing operations; (vii) the attainment of certain target levels of, or a specified percentage increase in, the Company's net sales, revenues, net income or earnings before income tax or
                  other exclusions; (viii) the attainment of certain target levels of, or a specified increase in, the Company's return on capital employed or return on invested capital; (ix) the attainment of certain target levels of, or a percentage
                  increase in, the Company's after-tax or pre-tax return on stockholder equity; (x) the attainment of certain target levels in the fair market value of the Company's Common Stock; (xi) the growth in the value of an investment in the Common
                  Stock assuming the reinvestment of dividends; (xii) the attainment of certain target levels of, or a specified increase in, EBITDA (earnings before income tax, depreciation and amortization); and/or attainment of synergies and cost
                  reductions in connection with mergers, acquisitions and similar corporate transactions involving the Company. In addition, Performance Goals may be based upon the attainment by a subsidiary, division or other operational unit of the
                  Company of specified levels of performance under one or more of the measures described above. Further, the Performance Goals may be based upon the attainment by the Company (or a subsidiary, division, facility or other operational unit of
                  the Company) of specified levels of performance under one or more of the foregoing measures relative to the performance of other corporations. Performance Goals may include a threshold level of performance below which no Award will be
                  earned, levels of performance at which an Award will become partially earned and a level at which an Award will be fully earned.

            

       

      
        8

        
          

      

      	

               	c.	
              Terms and Conditions.

            

       

      	

               	i.	
              Performance Shares and Performance Units. The applicable Award Agreement shall set forth (A) the number of Performance
                  Shares or the dollar value of Performance Units granted to the Participant; (B) the Performance Period and Performance Goals with respect to each such Award; (C) the threshold, target and maximum shares of Common Stock or dollar values of
                  each Performance Share or Performance Unit and corresponding Performance Goals; and (D) any other terms and conditions as the Committee determines in its sole and absolute discretion. The Committee shall establish, in its sole and
                  absolute discretion, the Performance Goals for the applicable Performance Period for each Performance Share or Performance; Unit granted hereunder. Performance Goals for different Participants and for different grants of Performance
                  Shares and Performance Units need not be identical. Unless otherwise provided in an Award Agreement, a holder of Performance Shares or Performance Units is not entitled to the rights of a holder of Common Stock.

            

       

      	

               	ii.	
              RSUs. The applicable Award Agreement shall set forth such terms and conditions with respect to the RSUs as the Committee
                  may impose, including restrictions on transferability, risk of forfeiture and other restrictions, if any, which restrictions may lapse separately or in combination at such times, under such circumstances, in such installments or otherwise
                  and under such other circumstances as the Committee may determine at the date of grant or thereafter.

            

       

      	

               	d.	
              Determination and Payment.

            

       

      	

               	i.	
              Performance Shares or Performance Units Earned. Following the end of a Performance Period, the Committee shall determine
                  the extent to which Performance Shares or Performance Units have been earned on the basis of the Company's actual performance in relation to the established Performance Goals as set forth in the applicable Award Agreement and shall
                  certify these results in writing. Unless otherwise provided in the Award Agreement, the payment with respect to Performance Shares or Performance Units shall be made within 60 days following the end of the applicable Performance Period.
                  Unless otherwise provided in an Award Agreement, the Committee shall determine in its sole and absolute discretion whether payment with respect to the Performance Share or Performance Unit shall be made in cash, in shares of Common Stock,
                  or in a combination thereof.

            

       

      
        9

        
          

      

      	

               	ii.	
              RSUs. Unless provided otherwise in the Award Agreement, Restricted Stock Units shall be paid within 60 days following the
                  date on which the restrictions on the RSUs lapse.

            

       

      	

               	e.	
              Termination of Employment. Unless otherwise provided in an Award Agreement, if a Participant's employment and other service with the
                  Company terminates for any reason, all of the Participant's outstanding RSUs that remain subject to restrictions as of the date of such termination shall be forfeited and Performance Shares and Performance Units shall be subject to the
                  rules of paragraph (i) and (ii) of this Section 9(e).

            

       

      	

               	i.	
              Termination for Reason Other Than Death or Disability. If a Participant's employment or other service with the Company
                  terminates prior to the expiration of a Performance Period with respect to any Performance Units or Performance Shares held by such Participant for any reason other than death or Disability, the outstanding Performance Units or
                  Performance Shares held by such Participant for which the Performance Period has not yet expired shall terminate upon such termination and the Participant shall have no further rights pursuant to such Performance Units or Performance
                  Shares.

            

       

      	

               	ii.	
              Termination of Employment for Death or Disability. If a Participant's employment or other service with the Company
                  terminates by reason of the Participant's death or Disability prior to the end of a Performance Period, the Participant, or the Participant's estate, devisee or heir at law (whichever is applicable) shall be entitled to a payment of the
                  Participant's outstanding Performance Units and Performance Shares, pursuant to the terms of the Plan and the Participant's Award Agreement; provided, however, that the Participant shall be deemed to have earned only that proportion (to
                  the nearest whole unit or share) of the Performance Units or Performance Shares granted to the Participant under such Award as the number of full months of the Performance Period which have elapsed since the first day of the Performance
                  Period for which the Award was granted to the end of the month in which the Participant's termination of employment or other service, bears to the total number of months in the Performance Period, subject to the attainment of the
                  Performance Goals associated with the Award as certified by the Committee. The remaining Performance Units or Performance Shares and any rights with respect thereto shall be canceled and forfeited.

            

       

      	10.	
              VESTING OF AWARD GRANTS TO NON-EMPLOYEE DIRECTORS

            

       

      Notwithstanding the minimum vesting provisions in Section 6(f) and 8(b) of the Plan, any Award granted to a Non-Employee Director in lieu of cash compensation shall not be subject
        to any minimum vesting requirements.

       

      	11.	
              OTHER AWARDS

            

       

      Awards of shares of Common Stock, phantom stock and other Awards that are valued in whole or in part by reference to, or otherwise based on, Common Stock, may also be made, from
        time to time, to Eligible Individuals as may be selected by the Committee. Such Awards may be issued in satisfaction of Awards granted under any other plan sponsored by the Company or compensation payable to an Eligible Individual. In addition,
        such Awards may be made alone or in addition to or in connection with any other Award granted hereunder. The Committee may determine the terms and conditions of any such Award, including conditioning such Awards on achievement of Performance Goals.
        Each such Award shall be evidenced by an Award Agreement between the Eligible Individual and the Company which shall specify the number of shares of Common Stock subject to the Award, any consideration therefore, any vesting or performance
        requirements and such other terms and conditions as the Committee shall determine in its sole and absolute discretion.

       

      
        10

        
          

      

      	12.	
              CHANGE IN CONTROL

            

       

      Upon the occurrence of a Change in Control of the Company, the Committee may in its sole and absolute discretion, provide on a case by case basis that (i) some or all outstanding
        Awards may become immediately exercisable or vested, without regard to any limitation imposed pursuant to this Plan, (ii) that all Awards shall terminate, provided that Participants shall have the right, immediately prior to the occurrence of such
        Change in Control and during such reasonable period as the Committee in its sole discretion shall determine and designate, to exercise any vested Award in whole or in part, (iii) that all Awards shall terminate, provided that Participants shall be
        entitled to a cash payment equal to the Change in Control Price with respect to shares subject to the vested portion of the Award net of the Exercise Price thereof, if applicable, (iv) provide that, in connection with a liquidation or dissolution
        of the Company, Awards, to the extent vested, shall convert into the right to receive liquidation proceeds net of the Exercise Price (if applicable), (v) accelerate the vesting of Awards, and (vi) any combination of the foregoing. In the event that
        the Committee does not terminate or convert an Award upon a Change in Control of the Company, then the Award shall be assumed, or substantially equivalent Awards shall be substituted, by the acquiring, or succeeding corporation (or an affiliate
        thereof).

       

      	13.	
              CHANGE IN STATUS OF PARENT OR SUBSIDIARY

            

       

      Unless otherwise provided in an Award Agreement or otherwise determined by the Committee, in the event that an entity or business unit which was previously a part of the Company is
        no longer a part of the Company, as determined by the Committee in its sole discretion, the Committee may, in its sole and absolute discretion: (i) provide on a case by case basis that some or all outstanding Awards held by a Participant employed
        by or performing service for such entity or business unit may become immediately exercisable or vested, without regard to any limitation imposed pursuant to this Plan; (ii) provide on a case by case basis that some or all outstanding Awards held by
        a Participant employed by or performing service for such entity or business unit may remain outstanding, may continue to vest, and/or may remain exercisable for a period not exceeding one (1) year, subject to the terms of the Award Agreement and
        this Plan; and/or (iii) treat the employment or other services of a Participant performing services for such entity or business unit as terminated if such Participant is not employed by Company or any entity that is a part of the Company
        immediately after such event.

       

      	14.	
              REQUIREMENTS OF LAW

            

       

      	

               	a.	
              Violations of Law. The Company shall not be required to make any payments, sell or issue any shares of Common Stock under any Award if
                  the sale or issuance of such shares would constitute a violation by the individual exercising the Award, the Participant or the Company of any provisions of any law or regulation of any governmental authority, including without limitation
                  any provisions of the Sarbanes-Oxley Act, and any other federal or state securities laws or regulations. Any determination in this connection by the Committee shall be final, binding, and conclusive. The Company shall not be obligated to
                  take any affirmative action in order to cause the exercise of an Award, the issuance of shares pursuant thereto, or the grant of an Award to comply with any law or regulation of any governmental authority.

            

       

      
        11

        
          

      

      	

               	b.	
              Registration. At the time of any exercise or receipt of any Award, the Company may, if it shall determine it necessary or desirable for
                  any reason, require the Participant (or Participant's heirs, legatees or legal representative, as the case may be), as a condition to the exercise or grant thereof, to deliver to the Company a written representation of present intention
                  to hold the shares for their own account as an investment and not with a view to, or for sale in connection with, the distribution of such shares, except in compliance with applicable federal and state securities laws with respect
                  thereto. In the event such representation is required to be delivered, an appropriate legend may be placed upon each certificate delivered to the Participant (or Participant's heirs, legatees or legal representative, as the case may be)
                  upon the Participant's exercise of part or all of the Award or receipt of an Award and a stop transfer order may be placed with the transfer agent. Each Award shall also be subject to the requirement that, if at any time the Company
                  determines, in its discretion, that the listing, registration or qualification of the shares subject to the Award upon any securities exchange or under any state or federal law, or the consent or approval of any governmental regulatory
                  body, is necessary or desirable as a condition of or in connection with, the issuance or purchase of the shares thereunder, the Award may not be exercised in whole or in part and the restrictions on an Award may not be removed unless such
                  listing, registration, qualification, consent or approval shall have been effected or obtained free of any conditions not acceptable to the Company in its sole discretion. The Participant shall provide the Company with any certificates,
                  representations and information that the Company requests and shall otherwise cooperate with the Company in obtaining any listing, registration, qualification, consent or approval that the Company deems necessary or appropriate. The
                  Company shall not be obligated to take any affirmative action in order to cause the exercisability or vesting of an Award, to cause the exercise of an Award or the issuance of shares pursuant thereto, or to cause the grant of Award to
                  comply with any law or regulation of any governmental authority.

            

       

      	

               	c.	
              Withholding. The Committee may make such provisions and take such steps as it may deem necessary or appropriate for the withholding of
                  any taxes that the Company is required by any law or regulation of any governmental authority, whether federal, state or local, domestic or foreign, to withhold in connection with the grant or exercise of an Award, or the removal of
                  restrictions on an Award including, but not limited to: (i) the withholding of delivery of shares of Common Stock until the holder reimburses the Company for the amount the Company is required to withhold with respect to such taxes; (ii)
                  the canceling of any number of shares of Common Stock issuable in an amount sufficient to reimburse the Company for the amount it is required to so withhold; (iii) withholding the amount due from any such person's wages or compensation
                  due to such person; or (iv) requiring the Participant to pay the Company cash in the amount the Company is required to withhold with respect to such taxes.

            

       

      	

               	d.	
              Governing Law. The Plan shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware.

            

       

      	15.	
              GENERAL PROVISIONS

            

       

      	

               	a.	
              Award Agreements. All Awards granted pursuant to the Plan shall be evidenced by an Award Agreement. Each Award Agreement shall specify
                  the terms and conditions of the Award granted and shall contain any additional provisions as the Committee shall deem appropriate, in its sole and absolute discretion (including, to the extent that the Committee deems appropriate,
                  provisions relating to confidentiality, non-competition, non-solicitation and similar matters). The terms of each Award Agreement need not be identical for Eligible Individuals provided that each Award Agreement shall comply with the
                  terms of the Plan.

            

       

      	

               	b.	
              Exemptions from Section 16(b) Liability. It is the intent of the Company that the grant of any Awards to or other transaction by a
                  Participant who is subject to Section 16 of the Exchange Act shall be exempt from Section 16 pursuant to an applicable exemption (except for transactions acknowledged in writing to be non-exempt by such Participant and sales transactions
                  to persons other than the Company). Accordingly, if any provision of this Plan or any Award Agreement does not comply with the requirements of Rule 16b-3 then applicable to any such transaction, such provision shall be construed or deemed
                  amended to the extent necessary to conform to the applicable requirements of Rule 16b-3 so that such Participant shall avoid liability under Section 16(b). In the event Rule 16b-3 is revised or replaced, the Board, or the Committee acting
                  on behalf of the Board, may exercise discretion to modify this Plan in any respect necessary to satisfy the requirements of the revised exemption or its replacement.

            

       

      
        12

        
          

      

      	

               	c.	
              Purchase Price. To the extent the purchase price of any Award granted hereunder is less than par value of a share of Common Stock and
                  such purchase price is not permitted by applicable law, the per share purchase price shall be deemed to be equal to the par value of a share of Common Stock.

            

       

      	

               	d.	
              Deferral of Awards. The Committee may from time to time establish procedures pursuant to which a Participant may elect to defer, until a
                  time or times later than the vesting of an Award, receipt of all or a portion of the shares of Common Stock or cash subject to such Award and to receive Common Stock or cash at such later time or times, all on such terms and conditions as
                  the Committee shall determine. The Committee shall not permit the deferral of an Award unless counsel for the Company determines that such action will not result in adverse tax consequences to a Participant under Section 409A of the Code.
                  If any such deferrals are permitted, then notwithstanding anything to the contrary herein, a Participant who elects to defer receipt of Common Stock shall not have any rights as a stockholder with respect to deferred shares of Common
                  Stock unless and until shares of Common Stock are actually delivered to the Participant with respect thereto, except to the extent otherwise determined by the Committee.

            

       

      	

               	e.	
              Prospective Employees. Notwithstanding anything to the contrary, any Award granted to a Prospective Employee shall not become vested
                  prior to the date the Prospective Employee first becomes an employee of the Company.

            

       

      	

               	f.	
              Stockholder Rights. Except as expressly provided in the Plan or an Award Agreement, a Participant shall not have any of the rights of a
                  stockholder with respect to Common Stock subject to the Awards prior to satisfaction of all conditions relating to the issuance of such Common Stock, and no adjustment shall be made for dividends, distributions or other rights of any kind
                  for which the record date is prior to the date on which all such conditions have been satisfied.

            

       

      	

               	g.	
              Transferability of Awards. A Participant may not Transfer an Award other than by will or the laws of descent and distribution. Awards
                  may be exercised during the Participant's lifetime only by the Participant. No Award shall be liable for or subject to the debts, contracts, or liabilities of any Participant, nor shall any Award be subject to legal process or attachment
                  for or against such person. Any purported Transfer of an Award in contravention of the provisions of the Plan shall have no force or effect and shall be null and void, and the purported transferee of such Award shall not acquire any
                  rights with respect to such Award. Notwithstanding anything to the contrary, the Committee may in its sole and absolute discretion permit the Transfer of an Award to a Participant's "family member" as such term is defined in the Form S-8
                  Registration Statement under the Securities Act of 1933, as amended, under such terms and conditions as specified by the Committee; provided, however, that the Participant will not directly or indirectly receive any payment of value in
                  connection with the transfer of the Award. In such case, such Award shall be exercisable only by the transferee approved of by the Committee. To the extent that the Committee permits the Transfer of an Incentive Stock Option to a "family
                  member", so that such Option fails to continue to satisfy the requirements of an incentive stock option under the Code such Option shall automatically be re-designated as a Non-Qualified Stock Option.

            

       

      	

               	h.	
              Buyout and Settlement Provisions. Except as prohibited hereunder, the Committee may at any time on behalf of the Company offer to buy
                  out any Awards previously granted based on such terms and conditions as the Committee shall determine which shall be communicated to the Participants at the time such offer is made.

            

       

      
        13

        
          

      

      	

               	i.	
              Use of Proceeds. The proceeds received by the Company from the sale of Common Stock pursuant to Awards granted under the Plan shall
                  constitute general funds of Company.

            

       

      	

               	j.	
              Modification or Substitution of an Award.

            

       

      	

               	i.	
              Generally. Subject to the terms and conditions of the Plan, the Award Agreement and applicable law (including the Code),
                  the Committee may modify outstanding Awards, provided that, except as permitted in the Plan or the applicable Award Agreement, no modification of an Award shall materially adversely affect any rights or obligations of the Participant
                  under the applicable Award Agreement without the Participant's consent. Nothing in the Plan shall limit the right of the Company to pay compensation of any kind outside the terms of the Plan.

            

       

      	

               	ii.	
              Limitation on Repricing. Unless such action is approved by the Company's shareholders in accordance with applicable law:
                  (i) no outstanding Option or Stock Appreciation Right granted under the Plan may be amended to provide an Exercise Price that is lower than the then-current Exercise Price of such outstanding Option or Stock Appreciation Right (other than
                  adjustments to the Exercise Price pursuant to Sections 5(e) and 12); (ii) the Committee may not cancel any outstanding Option or Stock Appreciation Right when its Exercise Price is equal to or greater than the Fair Market Value of the
                  underlying Common Stock and grant in substitution therefore new Awards, equity, cash or other property (other than adjustments pursuant to Section 12); (iii) the Committee may not authorize the repurchase of an outstanding Option or Stock
                  Appreciation Right which has an Exercise Price that is higher than the then-current fair market value of the Common Stock (other than adjustments pursuant to Section 12); (iv) the Committee may not cancel any outstanding Option or Stock
                  Appreciation Right and grant in substitution therefore new Awards as part of a strategy to materially enhance the position of the holder of such Options or Stock Appreciation Rights with respect to their value as of the time of such
                  substitution (other than adjustments pursuant to Section 12), and (v) the Committee may not take any other action that is treated as a repricing under generally accepted accounting principles (other than adjustments pursuant to Sections
                  5(e) and 12). A cancellation and exchange or substitution described in clauses (ii) and (iv) of the preceding sentence will be considered a repricing regardless of whether the Option, Restricted Stock or other equity is delivered
                  simultaneously with the cancellation, regardless of whether it is treated as a repricing under generally accepted accounting principles, and regardless of whether it is voluntary on the part of the Participant.

            

       

      	

               	k.	
              Amendment and Termination of Plan. The Board may, at any time and from time to time, amend, suspend or terminate the Plan as to any
                  shares of Common Stock as to which Awards have not been granted; provided, however, that the approval of the stockholders of the Company in accordance with applicable law and the Articles of
                  Incorporation and Bylaws of the Company shall be required for any amendment (other than those permitted under Section 5 or 12): (i) that changes the class of individuals eligible to receive Awards under the Plan; (ii) that increases the
                  maximum number of shares of Common Stock in the aggregate that may be subject to Awards that are granted under the Plan (except as permitted under Section 5 or Section 12 hereof); (iii) the approval of which is necessary to comply with
                  federal or state law (including without limitation Rule 16b-3 under the Exchange Act) or with the rules of any stock exchange or automated quotation system on which the Common Stock may be listed or traded; or (iv) that proposes to
                  eliminate a requirement provided herein that the stockholders of the Company must approve an action to be undertaken under the Plan. Except as expressly provided in the Plan, no amendment, suspension or termination of the Plan shall,
                  without the consent of the holder of an Award, alter or impair rights or obligations under any Award theretofore granted under the Plan. Awards granted prior to the termination of the Plan may extend beyond the date the Plan is terminated
                  and shall continue subject to the terms of the Plan as in effect on the date the Plan is terminated.

            

       

      
        14

        
          

      

      	

               	l.	
              Section 409A of the Code. The Award Agreement for any Award that the Committee reasonably determines to constitute "nonqualified"
                  deferred compensation plan" under Code Section 409A (a "Section 409A Plan"), and the provisions of the Plan applicable to that Award, shall be construed in a manner consistent with the applicable requirements of Code Section 409A,
                  and the Committee, in its sole discretion and without the consent of any Participant, may amend any Award Agreement (and the provisions of the Plan applicable thereto) if and to the extent that the Committee determines that such amendment
                  is necessary or appropriate to comply with the requirements of Code Section 409A. If any Award constitutes a Section 409A Plan, then the Award shall be subject to the following additional requirements, if and to the extent required to
                  comply with Code Section 409A:

            

       

      	

               	i.	
              Payments under the Section 409A Plan may not be made earlier than (u) the Participant's "separation from service", (v) the date the Participant becomes "disabled", (w) the Participant's death, (x) a "specified
                time (or pursuant to a fixed schedule)" specified in the Award Agreement at the date of the deferral of such compensation, (y) a "change in the ownership or effective control of the corporation, or in the ownership of a substantial portion
                of the assets: of the corporation, or (z) the occurrence of an "unforeseeable emergency";

            

       

      	

               	ii.	
              The time or schedule for any payment of the deferred compensation may not be accelerated, except to the extent provided in applicable Treasury Regulations or other applicable guidance issued by the Internal
                Revenue Service;

            

       

      	

               	iii.	
              Any elections with respect to the deferral of such compensation or the time and form of distribution of such deferred compensation shall comply with the requirements of Code Section 409A(a)(4); and

            

       

      	

               	iv.	
              In the case of any Participant who is a "specified employee", a distribution on account of a "separation from service" may not be made before the date which is six months after the date of the Participant's
                "separation from service" (or, if earlier, the date of the Participant's death).

            

       

      	

               	v.	
              For purposes of the foregoing, the terms in quotations shall have the same meanings as those terms have for purposes of Code Section 409A, and the limitations set forth herein shall be applied in such manner (and
                only to the extent) as shall be necessary to comply with any requirements of Code Section 409A that are applicable to the Award.

            

       

      	

               	m.	
              Notification of 83(b) Election. If in connection with the grant of any Award, any Participant makes an election permitted under Code
                  Section 83(b), such Participant must notify the Company in writing of such election within ten (10) days of filing such election with the Internal Revenue Service.

            

       

      
        15

        
          

      

      	

               	n.	
              Detrimental Activity. All Awards shall be subject to cancellation by the Committee in accordance with the terms of this Section 15(o) if
                  the Participant engages in any Detrimental Activity. To the extent that a Participant engages in any Detrimental Activity at any time prior to, or during the one year period after, any exercise or vesting of an Award but prior to a Change
                  in Control, the Company shall, upon the recommendation of the Committee, in its sole and absolute discretion, be entitled to (i) immediately terminate and cancel any Awards held by the Participant that have not yet been exercised, and/or
                  (ii) with respect to Awards of the Participant that have been previously exercised, recover from the Participant at any time within two (2) years after such exercise but prior to a Change in Control (and the Participant shall be obligated
                  to pay over to the Company with respect to any such Award previously held by such Participant): (A) with respect to any Options exercised, an amount equal to the excess of the Fair Market Value of the Common Stock for which any Option was
                  exercised over the Exercise Price paid (regardless of the form by which payment was made) with respect to such Option; (B) with respect to any Award other than an Option, any shares of Common Stock granted and vested pursuant to such
                  Award, and if such shares are not still owned by the Participant, the Fair Market Value of such shares on the date they were issued, or if later, the date all vesting restrictions were satisfied; and (C) any cash or other property (other
                  than Common Stock) received by the Participant from the Company pursuant to an Award. Without limiting the generality of the foregoing, in the event that a Participant engages in any Detrimental Activity at any time prior to any exercise
                  of an Award and the Company exercises its remedies pursuant to this Section 15(o) following the exercise of such Award, such exercise shall be treated as having been null and void, provided that the Company will nevertheless be entitled
                  to recover the amounts referenced above.

            

       

      	

               	o.	
              Disclaimer of Rights. No provision in the Plan, any Award granted hereunder, or any Award Agreement entered into pursuant to the Plan
                  shall be construed to confer upon any individual the right to remain in the employ of or other service with the Company or to interfere in any way with the right and authority of the Company either to increase or decrease the compensation
                  of any individual, including any holder of an Award, at any time, or to terminate any employment or other relationship between any individual and the Company. The grant of an Award pursuant to the Plan shall not affect or limit in any way
                  the right or power of the Company to make adjustments, reclassifications, reorganizations or changes of its capital or business structure or to merge, consolidate, dissolve or liquidate, or to sell or transfer all or any part of its
                  business or assets.

            

       

      	

               	p.	
              Unfunded Status of Plan. The Plan is intended to constitute an "unfunded" plan for incentive and deferred compensation. With respect to
                  any payments as to which a Participant has a fixed and vested interest but which are not yet made to such Participant by the Company, nothing contained herein shall give any such Participant any rights that are greater than those of a
                  general creditor of the Company

            

       

      	

               	q.	
              Nonexclusivity of Plan. The adoption of the Plan shall not be construed as creating any limitations upon the right and authority of the
                  Board to adopt such other incentive compensation arrangements (which arrangements may be applicable either generally to a class or classes of individuals or specifically to a particular individual or individuals) as the Board in its sole
                  and absolute discretion determines desirable.

            

       

      	

               	r.	
              Other Benefits. No Award payment under the Plan shall be deemed compensation for purposes of computing benefits under any retirement
                  plan of the Company or any agreement between a Participant and the Company, nor affect any benefits under any other benefit plan of the Company now or subsequently in effect under which benefits are based upon a Participant's level of
                  compensation.

            

       

      	

               	s.	
              Headings. The section headings in the Plan are for convenience only; they form no part of this Agreement and shall not affect its
                  interpretation.

            

       

      	

               	t.	
              Pronouns. The use of any gender in the Plan shall be deemed to include all genders, and the use of the singular shall be deemed to
                  include the plural and vice versa, wherever it appears appropriate from the context.

            

       

      
        16

        
          

      

      	

               	u.	
              Successors and Assigns. The Plan shall be binding on all successors of the Company and all successors and permitted assigns of a
                  Participant, including, but not limited to, a Participant's estate, devisee, or heir at law.

            

       

      	

               	v.	
              Severability. If any provision of the Plan or any Award Agreement shall be determined to be illegal or unenforceable by any court of law
                  in any jurisdiction, the remaining provisions hereof and thereof shall be severable and enforceable in accordance with their terms, and all provisions shall remain enforceable in any other jurisdiction.

            

       

      	

               	w.	
              Notices. Any communication or notice required or permitted to be given under the Plan shall be in writing, and mailed by registered or
                  certified mail or delivered by hand, to the Company, to its principal place of business, attention: Chief Financial Officer and if to the holder of an Award, to the address as appearing on the records of the Company.

            

       

      
        17

        
          

      

      APPENDIX A

       

      DEFINITIONS

       

      "Award" means any Common Stock, Option, Performance Share, Performance Unit, Restricted Stock, RSUs, Stock Appreciation Right or any other award granted pursuant to the Plan.

       

      "Award Agreement" means a written agreement entered into by the Company and a Participant setting forth the terms and conditions of the grant of an Award to such Participant.

       

      "Board" means the board of directors of the Company.

       

      "Cause" means, with respect to a termination of employment or other service with the Company Group, a termination of employment or other service due to a Participant's dishonesty,
        fraud, insubordination, willful misconduct, refusal to perform services (for any reason other than illness or incapacity) or materially unsatisfactory performance of the Participant's duties for the Company Group, including a voluntary termination
        within ninety (90) days after occurrence of an event which would be grounds for termination of employment or other service by the Company Group for Cause (without regard to any notice or cure period requirement); provided,
          however, that if the Participant and the Company Group have entered into an employment agreement or consulting agreement which defines the term Cause, the term Cause shall be defined in accordance with such agreement with respect to any
        Award granted to the Participant on or after the effective date of the respective employment or consulting agreement. The Committee shall determine in its sole and absolute discretion whether Cause exists for purposes of the Plan.

       

      "Change in Control" shall be deemed to occur upon occurrence of any of the following after the Effective Date:

       

      	

               	(a)	
              any "person" as such term is used in Sections 13(d) and 14(d) of the Exchange Act (other than the Company, any trustee or other fiduciary holding securities under any employee benefit plan of the Company, any
                company owned, directly or indirectly, by the stockholders of the Company in substantially the same proportions as their ownership of common stock of the Company is or becomes the "beneficial owner" (as defined in Rule 13d-3 under the
                Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the combined voting power of the Company's then outstanding securities;

            

       

      	

               	(b)	
              during any period of two (2) consecutive years, individuals who at the beginning of such period constitute the Board, and any new director (other than a director designated by a person who has entered into an
                agreement with the Company to effect a transaction described in paragraph (a), (c), or (d) of this Section) whose election by the Board or nomination for election by the Company's stockholders was approved by a vote of at least two-thirds
                of the directors then still in office who either were directors at the beginning of the two-year period or whose election or nomination for election was previously so approved, cease for any reason to constitute at least a majority of the
                Board;

            

       

      	

               	(c)	
              a merger, consolidation, reorganization, or other business combination of the Company with any other entity, other than a merger or consolidation which would result in the voting securities of the Company
                outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity) more than fifty percent (50%) of the combined voting power of the voting
                securities of the Company or such surviving entity outstanding immediately after such merger or consolidation; provided, however, that a merger or consolidation effected to implement a recapitalization of the Company (or similar
                transaction) in which no person acquires more than twenty-five percent (25%) of the combined voting power of the Company's then outstanding securities shall not constitute a Change in Control; or

            

       

      
        18

        
          

      

      	

               	(d)	
              complete liquidation of the Company or the consummation of the sale or disposition by the Company of all or substantially all of the Company's assets other than (x) the sale or disposition of all or substantially
                all of the assets of the Company to a person or persons who beneficially own, directly or indirectly, at least fifty percent (50%) or more of the combined voting power of the outstanding voting securities of the Company at the time of the
                sale or (y) pursuant to a spin-off type transaction, directly or indirectly, of such assets to the stockholders of the Company.

            

       

      However, to the extent that Code Section 409A would cause an adverse tax consequence to a Participant using the above definition, the term "Change in Control" shall have the
        meaning ascribed to the phrase "Change in the Ownership or Effective Control of a Corporation or in the Ownership of a Substantial Portion of the Assets of a Corporation" under Treasury Department Regulation 1.409A-3(g)(5), as revised from time to
        time in subsequent regulations, and in the event that such regulations are withdrawn or such phrase (or a substantially similar phrase) ceases to be defined, as determined by the Committee.

       

      "Change in Control Price" means the price per share of Common Stock paid in any transaction related to a Change in Control of the Company. "Code" means the Internal Revenue Code of
        1986, as amended, and the regulations promulgated thereunder.

       

      "Committee" means a committee or sub-committee of the Board consisting of two or more members of the Board, none of whom shall be an officer or other salaried employee of the
        Company, and each of whom shall qualify in all respects as a "non-employee director" as defined in Rule 16b-3 under the Exchange Act. If no Committee exists, the functions of the Committee will be exercised by the Board. Notwithstanding the
        foregoing, with respect to the grant of Awards to non-employee directors, the Committee shall be the Board.

       

      "Common Stock" means the common stock, par value $0.005 per share, of the Company or any other security into which such common stock shall be changed as contemplated by the
        adjustment provisions of the Plan.

       

      "Company Group" means Brooklyn Immunotherapeutics, Inc. (f/k/a NTN Buzztime, Inc.), a Delaware corporation, any subsidiary of Brooklyn Immunotherapeutics, Inc. and all other
        entities whose financial statements are required to be consolidated with the financial statements of Brooklyn Immunotherapeutics, Inc. pursuant to United States generally accepted accounting principles, and any other entity determined to be an
        affiliate of Brooklyn Immunotherapeutics, Inc. as determined by the Committee in its sole and absolute discretion. Company Group's composition may not be the same for different purposes or Awards under the Plan.

       

      "Covered Individual" means any current or former member of the Committee, any current or former officer or director of the Company, or, if so determined by the Committee in its
        sole discretion, any individual designated pursuant to Section 4(c).

       

      "Detrimental Activity" means any of the following: (i) the disclosure to anyone outside the Company, or the use in other than the Company's business, without written authorization
        from the Company, of any confidential information or proprietary information, relating to the business of the Company, acquired by a Participant prior to a termination of the Participant's employment or service with the Company; (ii) activity while
        employed or providing services that is classified by the Company as a basis for a termination for Cause; (iii) the Participant's Disparagement, or inducement of others to do so, of the Company or its past or present officers, directors, employees
        or services; or (iv) any other conduct or act determined by the Committee, in its sole discretion, to be injurious, detrimental or prejudicial to the interests of the Company. For purposes of subparagraph (i) above, the Chief Executive Officer of
        the Company shall have authority to provide the Participant with written authorization to engage in the activities contemplated thereby and no other person shall have authority to provide the Participant with such authorization.

       

      
        19

        
          

      

      "Disability" means a "permanent and total disability" within the meaning of Code Section 22(e)(3); provided, however, that if a
        Participant and the Company have entered into an employment or consulting agreement which defines the term Disability for purposes of such agreement, Disability shall be defined pursuant to the definition in such agreement with respect to any Award
        granted to the Participant on or after the effective date of the respective employment or consulting agreement. The Committee shall determine in its sole and absolute discretion whether a Disability exists for purposes of the Plan.

       

      "Disparagement" means making any comments or statements to the press, the Company's employees, clients or any other individuals or entities with whom the Company has a business
        relationship, which could adversely affect in any manner: (i) the conduct of the business of the Company (including, without limitation, any products or business plans or prospects), or (ii) the business reputation of the Company or any of its
        products, or its past or present officers, directors or employees.

       

      "Dividend Equivalents" means an amount equal to the cash dividends paid by the Company upon one share of Common Stock subject to an Award granted to a Participant under the Plan.

       

      "Effective Date" shall mean the Effective Date as defined in Section 1 of the Plan.

       

      "Eligible Individual" means any employee, officer, director (employee or non-employee director), consultant, or independent contractor of the Company and any Prospective Employee
        to whom Awards are granted in connection with an offer of future employment with the Company.

       

      "Exchange Act" means the Securities Exchange Act of 1934, as amended.

       

      "Exercise Price" means the purchase price per share of each share of Common Stock subject to an Award.

       

      "Fair Market Value" means, unless otherwise required by the Code, as of any date, the last sales price reported for the Common Stock on the day immediately prior to such date (i)
        as reported by the national securities exchange in the United States on which it is then traded, or (ii) if not traded on any such national securities exchange, as quoted on an automated quotation system sponsored by the Financial Industry
        Regulatory Authority, Inc., or if the Common Stock shall not have been reported or quoted on such date, on the first day prior thereto on which the Common Stock was reported or quoted; provided, however, that
        the Committee may modify the definition of Fair Market Value to reflect any changes in the trading practices of any exchange or automated system sponsored by the Financial Industry Regulatory Authority, Inc. on which the Common Stock is listed or
        traded. If the Common Stock is not readily traded on a national securities exchange or any system sponsored by the Financial Industry Regulatory Authority, Inc., the Fair Market Value shall be determined in good faith by the Committee.

       

      "Grant Date" means, unless otherwise provided by applicable law, the date on which the Committee approves the grant of an Award or such later date as is specified by the Committee
        and set forth in the applicable Award Agreement.

       

      "Incentive Stock Option" means an "incentive stock option" within the meaning of Code Section 422.

       

      "Non-Employee Director" means a director of the Company who is not an active employee of the Company.

       

      "Non-Qualified Stock Option" means an Option which is not an Incentive Stock Option.

       

      "Option" means an option to purchase Common Stock granted pursuant to Sections 6 of the Plan.

       

      
        20

        
          

      

      "Participant" means any Eligible Individual who holds an Award under the Plan and any of such individual's successors or permitted assigns.

       

      "Performance Goals" means the specified performance goals which have been established by the Committee in connection with an Award.

       

      "Performance Period" means the period during which Performance Goals must be achieved in connection with an Award granted under the Plan.

       

      "Performance Share" means a right to receive a fixed number of shares of Common Stock, or the cash equivalent, which is contingent on the achievement of certain Performance Goals
        during a Performance Period.

       

      "Performance Unit" means a right to receive a designated dollar value, or shares of Common Stock of the equivalent value, which is contingent on the achievement of Performance
        Goals during a Performance Period.

       

      "Person" shall mean any person, corporation, partnership, limited liability company, joint venture or other entity or any group (as such term is defined for purposes of Section
        13(d) of the Exchange Act), other than a Parent or subsidiary of the Company.

       

      "Plan" means this Brooklyn Immunotherapeutics, Inc. 2020 Stock Incentive Plan.

       

      "Prospective Employee" means any individual who has committed to become an employee or independent contractor of the Company within sixty (60) days from the date an Award is
        granted to such individual.

       

      "Restricted Stock" means Common Stock subject to certain restrictions, as determined by the Committee, and granted pursuant to Section 8 hereunder.

       

      "RSU" means a right, granted under Section 9 hereof, to receive Common Stock at the end of a specified period.

       

      "Section 424 Employee" means an employee of the Company or any "subsidiary corporation" or "parent corporation" as such terms are defined in and in accordance with Code Section
        424. The term "Section 424 Employee" also includes employees of a corporation issuing or assuming any Options in a transaction to which Code Section 424(a) applies.

       

      "Stock Appreciation Right" means the right to receive all or some portion of the increase in value of a fixed number of shares of Common Stock granted pursuant to Section 7
        hereunder.

       

      "Transfer" means, as a noun, any direct or indirect, voluntary or involuntary, exchange, sale, bequeath, pledge, mortgage, hypothecation, encumbrance, distribution, transfer, gift,
        assignment or other disposition or attempted disposition of, and, as a verb, directly or indirectly, voluntarily or involuntarily, to exchange, sell, bequeath, pledge, mortgage, hypothecate, encumber, distribute, transfer, give, assign or in any
        other manner whatsoever dispose or attempt to dispose of.

       

       

         

       21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]